 The purpose of this study is to evaluate the safety and effectiveness of infliximab Remicade in patients with Chronic Obstructive Pulmonary Disease COPD. Infliximab Remicade targets specific proteins in the bodys immune system to help control the development of inflammation to help reduce painful disease. 